Sawicka-Gutaj, N., Ziółkowska, P., Derwich, A., Gut, P., Czarnywojtek, A., Kloska, M., & Ruchała, M. (2022). Is eNAMPT/visfatin a potential serum marker of papillary thyroid cancer? SAGE Publishing.
Παραπομπή Chicago StyleSawicka-Gutaj, Nadia, Paulina Ziółkowska, Aleksandra Derwich, Paweł Gut, Agata Czarnywojtek, Michał Kloska, και Marek Ruchała. Is ENAMPT/visfatin a Potential Serum Marker of Papillary Thyroid Cancer? SAGE Publishing, 2022.
Παραπομπή MLASawicka-Gutaj, Nadia, et al. Is ENAMPT/visfatin a Potential Serum Marker of Papillary Thyroid Cancer? SAGE Publishing, 2022.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.